Neuropsychiatric researchers are at the forefront of understanding how neurological and psychiatric conditions intersect, studying disorders that involve both brain function and mental health. These include complex conditions like schizophrenia, bipolar disorder, autism spectrum disorders, depression with cognitive impairment, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Through clinical studies, brain imaging, genetic analysis, and behavioral assessments, neuropsychiatric researchers investigate how structural and chemical changes in the brain affect mood, cognition, and behavior. Their work is essential for identifying biological markers and mechanisms that contribute to these conditions, ultimately helping to develop more targeted and effective treatments.
In both clinical and academic settings, neuropsychiatric researchers collaborate with neurologists, psychiatrists, neuroscientists, and pharmacologists to bridge the gap between brain science and mental health care. Their research not only informs new drug development but also shapes non-pharmacological interventions like cognitive behavioral therapy, neuromodulation, and lifestyle-based treatments. They also play a key role in refining diagnostic criteria and identifying early warning signs of disease onset. As mental health becomes more widely recognized as a critical component of neurological wellness, the contributions of neuropsychiatric researchers are more important than ever. Their commitment to unraveling the complex brain-mind connection continues to transform the way we understand, diagnose, and manage neuropsychiatric conditions.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom